> top > docs > PubMed:11964077 > annotations

PubMed:11964077 JSONTXT

Annnotations TAB JSON ListView MergeView

sentences

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-143 Sentence denotes Interleukin-8 and vascular endothelial growth factor mRNA and protein levels are down-regulated in ovarian carcinoma cells in serous effusions.
TextSentencer_T2 144-203 Sentence denotes Angiogenic factors are involved in tumor growth and spread.
TextSentencer_T3 204-391 Sentence denotes The aim of this study was to evaluate the expression of angiogenesis-related genes in malignant serous effusions of patients with advanced-stage (FIGO stage III and IV) ovarian carcinoma.
TextSentencer_T4 392-553 Sentence denotes In addition, to compare the results for carcinoma cells in effusions with corresponding primary tumors and metastatic lesions, and analyze their prognostic role.
TextSentencer_T5 554-850 Sentence denotes Sections from 66 effusions and 90 primary and metastatic lesions from 62 ovarian and primary peritoneal carcinoma patients, were evaluated for expression of basic fibroblast factor (bFGF), interleukin-8 (IL-8), and vascular endothelial growth factor (VEGF) using mRNA in situ hybridization (ISH).
TextSentencer_T6 851-942 Sentence denotes Protein expression was evaluated in a subset of specimens using immunohistochemistry (IHC).
TextSentencer_T7 943-996 Sentence denotes ISH results were correlated with clinical parameters.
TextSentencer_T8 997-1238 Sentence denotes In both effusions and solid tumors, bFGF mRNA was the most commonly expressed factor (93% of effusions and 95% of solid tumors) followed by IL-8, while VEGF was expressed in a minority of the specimens (P < 0.001 for bFGF vs. IL-8 and VEGF).
TextSentencer_T9 1239-1358 Sentence denotes In solid tumors, angiogenic mRNA expression was seen in both tumor and stromal cells in the majority of positive cases.
TextSentencer_T10 1359-1419 Sentence denotes ISH results did not differ in primary and metastatic tumors.
TextSentencer_T11 1420-1578 Sentence denotes However, carcinoma cells in effusions showed down-regulated expression of VEGF, when compared with both primary tumors (P = 0.029) and metastases (P = 0.015).
TextSentencer_T12 1579-1673 Sentence denotes IL-8 showed a similar down-regulation in effusions, when compared with metastases (P = 0.005).
TextSentencer_T13 1674-1741 Sentence denotes IHC showed excellent agreement with mRNA findings on protein level.
TextSentencer_T14 1742-1874 Sentence denotes In the study of clinico-pathologic parameters, IL-8 mRNA expression in effusions was associated with higher tumor grade (P = 0.044).
TextSentencer_T15 1875-2058 Sentence denotes Angiogenic gene expression in effusions showed no correlation with patient age, previous treatment, residual tumor size, FIGO stage or disease outcome in survival analysis (P > 0.05).
TextSentencer_T16 2059-2127 Sentence denotes Peritoneal and pleural effusions showed similar expression patterns.
TextSentencer_T17 2128-2228 Sentence denotes In conclusion, bFGF is the major angiogenic factor expressed in ovarian carcinoma at the mRNA level.
TextSentencer_T18 2229-2556 Sentence denotes It is highly expressed in both solid tumors and serous effusions, while IL-8 and VEGF are down regulated in carcinoma cells in effusions, possibly due to the lack of interaction with stromal cells. mRNA expression of VEGF, bFGF, and IL-8 does not appear to be a predictor of disease outcome in advanced-stage ovarian carcinoma.
TextSentencer_T19 2557-2772 Sentence denotes Carcinoma cells in pleural and peritoneal effusions show a similar metastatic expression profile, in agreement with our previous findings, supporting the true metastatic nature of ovarian carcinoma cells in ascites.
T1 0-143 Sentence denotes Interleukin-8 and vascular endothelial growth factor mRNA and protein levels are down-regulated in ovarian carcinoma cells in serous effusions.
T2 144-203 Sentence denotes Angiogenic factors are involved in tumor growth and spread.
T3 204-391 Sentence denotes The aim of this study was to evaluate the expression of angiogenesis-related genes in malignant serous effusions of patients with advanced-stage (FIGO stage III and IV) ovarian carcinoma.
T4 392-553 Sentence denotes In addition, to compare the results for carcinoma cells in effusions with corresponding primary tumors and metastatic lesions, and analyze their prognostic role.
T5 554-850 Sentence denotes Sections from 66 effusions and 90 primary and metastatic lesions from 62 ovarian and primary peritoneal carcinoma patients, were evaluated for expression of basic fibroblast factor (bFGF), interleukin-8 (IL-8), and vascular endothelial growth factor (VEGF) using mRNA in situ hybridization (ISH).
T6 851-942 Sentence denotes Protein expression was evaluated in a subset of specimens using immunohistochemistry (IHC).
T7 943-996 Sentence denotes ISH results were correlated with clinical parameters.
T8 997-1238 Sentence denotes In both effusions and solid tumors, bFGF mRNA was the most commonly expressed factor (93% of effusions and 95% of solid tumors) followed by IL-8, while VEGF was expressed in a minority of the specimens (P < 0.001 for bFGF vs. IL-8 and VEGF).
T9 1239-1358 Sentence denotes In solid tumors, angiogenic mRNA expression was seen in both tumor and stromal cells in the majority of positive cases.
T10 1359-1419 Sentence denotes ISH results did not differ in primary and metastatic tumors.
T11 1420-1578 Sentence denotes However, carcinoma cells in effusions showed down-regulated expression of VEGF, when compared with both primary tumors (P = 0.029) and metastases (P = 0.015).
T12 1579-1673 Sentence denotes IL-8 showed a similar down-regulation in effusions, when compared with metastases (P = 0.005).
T13 1674-1741 Sentence denotes IHC showed excellent agreement with mRNA findings on protein level.
T14 1742-1874 Sentence denotes In the study of clinico-pathologic parameters, IL-8 mRNA expression in effusions was associated with higher tumor grade (P = 0.044).
T15 1875-2058 Sentence denotes Angiogenic gene expression in effusions showed no correlation with patient age, previous treatment, residual tumor size, FIGO stage or disease outcome in survival analysis (P > 0.05).
T16 2059-2127 Sentence denotes Peritoneal and pleural effusions showed similar expression patterns.
T17 2128-2228 Sentence denotes In conclusion, bFGF is the major angiogenic factor expressed in ovarian carcinoma at the mRNA level.
T18 2229-2556 Sentence denotes It is highly expressed in both solid tumors and serous effusions, while IL-8 and VEGF are down regulated in carcinoma cells in effusions, possibly due to the lack of interaction with stromal cells. mRNA expression of VEGF, bFGF, and IL-8 does not appear to be a predictor of disease outcome in advanced-stage ovarian carcinoma.
T19 2557-2772 Sentence denotes Carcinoma cells in pleural and peritoneal effusions show a similar metastatic expression profile, in agreement with our previous findings, supporting the true metastatic nature of ovarian carcinoma cells in ascites.

DisGeNET5_gene_disease

Id Subject Object Predicate Lexical cue
11964077-0#0#13#gene3576 392-756 gene3576 denotes In addition, to compare the results for carcinoma cells in effusions with corresponding primary tumors and metastatic lesions, and analyze their prognostic role. Sections from 66 effusions and 90 primary and metastatic lesions from 62 ovarian and primary peritoneal carcinoma patients, were evaluated for expression of basic fibroblast factor (bFGF), interleukin-8
11964077-0#18#52#gene7422 769-803 gene7422 denotes vascular endothelial growth factor
11964077-0#99#116#diseaseC0029925 1491-2105 diseaseC0029925 denotes of VEGF, when compared with both primary tumors (P = 0.029) and metastases (P = 0.015). IL-8 showed a similar down-regulation in effusions, when compared with metastases (P = 0.005). IHC showed excellent agreement with mRNA findings on protein level. In the study of clinico-pathologic parameters, IL-8 mRNA expression in effusions was associated with higher tumor grade (P = 0.044). Angiogenic gene expression in effusions showed no correlation with patient age, previous treatment, residual tumor size, FIGO stage or disease outcome in survival analysis (P > 0.05). Peritoneal and pleural effusions showed simila
11964077-0#99#116#diseaseC0677886 1491-2105 diseaseC0677886 denotes of VEGF, when compared with both primary tumors (P = 0.029) and metastases (P = 0.015). IL-8 showed a similar down-regulation in effusions, when compared with metastases (P = 0.005). IHC showed excellent agreement with mRNA findings on protein level. In the study of clinico-pathologic parameters, IL-8 mRNA expression in effusions was associated with higher tumor grade (P = 0.044). Angiogenic gene expression in effusions showed no correlation with patient age, previous treatment, residual tumor size, FIGO stage or disease outcome in survival analysis (P > 0.05). Peritoneal and pleural effusions showed simila
11964077-0#99#116#diseaseC0029925 1491-2105 diseaseC0029925 denotes of VEGF, when compared with both primary tumors (P = 0.029) and metastases (P = 0.015). IL-8 showed a similar down-regulation in effusions, when compared with metastases (P = 0.005). IHC showed excellent agreement with mRNA findings on protein level. In the study of clinico-pathologic parameters, IL-8 mRNA expression in effusions was associated with higher tumor grade (P = 0.044). Angiogenic gene expression in effusions showed no correlation with patient age, previous treatment, residual tumor size, FIGO stage or disease outcome in survival analysis (P > 0.05). Peritoneal and pleural effusions showed simila
11964077-0#99#116#diseaseC0677886 1491-2105 diseaseC0677886 denotes of VEGF, when compared with both primary tumors (P = 0.029) and metastases (P = 0.015). IL-8 showed a similar down-regulation in effusions, when compared with metastases (P = 0.005). IHC showed excellent agreement with mRNA findings on protein level. In the study of clinico-pathologic parameters, IL-8 mRNA expression in effusions was associated with higher tumor grade (P = 0.044). Angiogenic gene expression in effusions showed no correlation with patient age, previous treatment, residual tumor size, FIGO stage or disease outcome in survival analysis (P > 0.05). Peritoneal and pleural effusions showed simila
11964077-10#74#78#gene7422 1494-1498 gene7422 denotes VEGF
11964077-10#135#145#diseaseC0027627 1555-1565 diseaseC0027627 denotes metastases
11964077-11#0#4#gene3576 1579-1583 gene3576 denotes IL-8
11964077-11#71#81#diseaseC0027627 1650-1660 diseaseC0027627 denotes metastases
11964077-17#72#76#gene3576 2301-2305 gene3576 denotes IL-8
11964077-17#81#85#gene7422 2310-2314 gene7422 denotes VEGF
11964077-17#217#221#gene7422 2446-2450 gene7422 denotes VEGF
11964077-17#233#237#gene3576 2462-2466 gene3576 denotes IL-8
11964077-17#31#43#diseaseC0280100 2260-2272 diseaseC0280100 denotes solid tumors
11964077-17#303#326#diseaseC0280220 2532-2555 diseaseC0280220 denotes stage ovarian carcinoma
11964077-17#31#43#diseaseC0280100 2260-2272 diseaseC0280100 denotes solid tumors
11964077-17#303#326#diseaseC0280220 2532-2555 diseaseC0280220 denotes stage ovarian carcinoma
11964077-17#31#43#diseaseC0280100 2260-2272 diseaseC0280100 denotes solid tumors
11964077-17#303#326#diseaseC0280220 2532-2555 diseaseC0280220 denotes stage ovarian carcinoma
11964077-4#189#202#gene3576 743-756 gene3576 denotes interleukin-8
11964077-4#215#249#gene7422 769-803 gene7422 denotes vascular endothelial growth factor
11964077-4#251#255#gene7422 805-809 gene7422 denotes VEGF
11964077-4#85#113#diseaseC1514428 639-667 diseaseC1514428 denotes primary peritoneal carcinoma
0#13#gene357699#116#diseaseC0029925 11964077-0#0#13#gene3576 11964077-0#99#116#diseaseC0029925 associated_with "In addition, to compare the results for carcinoma cells in effusions with corresponding primary tumors and metastatic lesions, and analyze their prognostic role. Sections from 66 effusions and 90 primary and metastatic lesions from 62 ovarian and primary peritoneal carcinoma patients, were evaluated for expression of basic fibroblast factor (bFGF), interleukin-8","of VEGF, when compared with both primary tumors (P = 0.029) and metastases (P = 0.015). IL-8 showed a similar down-regulation in effusions, when compared with metastases (P = 0.005). IHC showed excellent agreement with mRNA findings on protein level. In the study of clinico-pathologic parameters, IL-8 mRNA expression in effusions was associated with higher tumor grade (P = 0.044). Angiogenic gene expression in effusions showed no correlation with patient age, previous treatment, residual tumor size, FIGO stage or disease outcome in survival analysis (P > 0.05). Peritoneal and pleural effusions showed simila"
0#13#gene357699#116#diseaseC0677886 11964077-0#0#13#gene3576 11964077-0#99#116#diseaseC0677886 associated_with "In addition, to compare the results for carcinoma cells in effusions with corresponding primary tumors and metastatic lesions, and analyze their prognostic role. Sections from 66 effusions and 90 primary and metastatic lesions from 62 ovarian and primary peritoneal carcinoma patients, were evaluated for expression of basic fibroblast factor (bFGF), interleukin-8","of VEGF, when compared with both primary tumors (P = 0.029) and metastases (P = 0.015). IL-8 showed a similar down-regulation in effusions, when compared with metastases (P = 0.005). IHC showed excellent agreement with mRNA findings on protein level. In the study of clinico-pathologic parameters, IL-8 mRNA expression in effusions was associated with higher tumor grade (P = 0.044). Angiogenic gene expression in effusions showed no correlation with patient age, previous treatment, residual tumor size, FIGO stage or disease outcome in survival analysis (P > 0.05). Peritoneal and pleural effusions showed simila"
0#13#gene357699#116#diseaseC0029925 11964077-0#0#13#gene3576 11964077-0#99#116#diseaseC0029925 associated_with "In addition, to compare the results for carcinoma cells in effusions with corresponding primary tumors and metastatic lesions, and analyze their prognostic role. Sections from 66 effusions and 90 primary and metastatic lesions from 62 ovarian and primary peritoneal carcinoma patients, were evaluated for expression of basic fibroblast factor (bFGF), interleukin-8","of VEGF, when compared with both primary tumors (P = 0.029) and metastases (P = 0.015). IL-8 showed a similar down-regulation in effusions, when compared with metastases (P = 0.005). IHC showed excellent agreement with mRNA findings on protein level. In the study of clinico-pathologic parameters, IL-8 mRNA expression in effusions was associated with higher tumor grade (P = 0.044). Angiogenic gene expression in effusions showed no correlation with patient age, previous treatment, residual tumor size, FIGO stage or disease outcome in survival analysis (P > 0.05). Peritoneal and pleural effusions showed simila"
0#13#gene357699#116#diseaseC0677886 11964077-0#0#13#gene3576 11964077-0#99#116#diseaseC0677886 associated_with "In addition, to compare the results for carcinoma cells in effusions with corresponding primary tumors and metastatic lesions, and analyze their prognostic role. Sections from 66 effusions and 90 primary and metastatic lesions from 62 ovarian and primary peritoneal carcinoma patients, were evaluated for expression of basic fibroblast factor (bFGF), interleukin-8","of VEGF, when compared with both primary tumors (P = 0.029) and metastases (P = 0.015). IL-8 showed a similar down-regulation in effusions, when compared with metastases (P = 0.005). IHC showed excellent agreement with mRNA findings on protein level. In the study of clinico-pathologic parameters, IL-8 mRNA expression in effusions was associated with higher tumor grade (P = 0.044). Angiogenic gene expression in effusions showed no correlation with patient age, previous treatment, residual tumor size, FIGO stage or disease outcome in survival analysis (P > 0.05). Peritoneal and pleural effusions showed simila"
18#52#gene742299#116#diseaseC0029925 11964077-0#18#52#gene7422 11964077-0#99#116#diseaseC0029925 associated_with vascular endothelial growth factor,"of VEGF, when compared with both primary tumors (P = 0.029) and metastases (P = 0.015). IL-8 showed a similar down-regulation in effusions, when compared with metastases (P = 0.005). IHC showed excellent agreement with mRNA findings on protein level. In the study of clinico-pathologic parameters, IL-8 mRNA expression in effusions was associated with higher tumor grade (P = 0.044). Angiogenic gene expression in effusions showed no correlation with patient age, previous treatment, residual tumor size, FIGO stage or disease outcome in survival analysis (P > 0.05). Peritoneal and pleural effusions showed simila"
18#52#gene742299#116#diseaseC0677886 11964077-0#18#52#gene7422 11964077-0#99#116#diseaseC0677886 associated_with vascular endothelial growth factor,"of VEGF, when compared with both primary tumors (P = 0.029) and metastases (P = 0.015). IL-8 showed a similar down-regulation in effusions, when compared with metastases (P = 0.005). IHC showed excellent agreement with mRNA findings on protein level. In the study of clinico-pathologic parameters, IL-8 mRNA expression in effusions was associated with higher tumor grade (P = 0.044). Angiogenic gene expression in effusions showed no correlation with patient age, previous treatment, residual tumor size, FIGO stage or disease outcome in survival analysis (P > 0.05). Peritoneal and pleural effusions showed simila"
18#52#gene742299#116#diseaseC0029925 11964077-0#18#52#gene7422 11964077-0#99#116#diseaseC0029925 associated_with vascular endothelial growth factor,"of VEGF, when compared with both primary tumors (P = 0.029) and metastases (P = 0.015). IL-8 showed a similar down-regulation in effusions, when compared with metastases (P = 0.005). IHC showed excellent agreement with mRNA findings on protein level. In the study of clinico-pathologic parameters, IL-8 mRNA expression in effusions was associated with higher tumor grade (P = 0.044). Angiogenic gene expression in effusions showed no correlation with patient age, previous treatment, residual tumor size, FIGO stage or disease outcome in survival analysis (P > 0.05). Peritoneal and pleural effusions showed simila"
18#52#gene742299#116#diseaseC0677886 11964077-0#18#52#gene7422 11964077-0#99#116#diseaseC0677886 associated_with vascular endothelial growth factor,"of VEGF, when compared with both primary tumors (P = 0.029) and metastases (P = 0.015). IL-8 showed a similar down-regulation in effusions, when compared with metastases (P = 0.005). IHC showed excellent agreement with mRNA findings on protein level. In the study of clinico-pathologic parameters, IL-8 mRNA expression in effusions was associated with higher tumor grade (P = 0.044). Angiogenic gene expression in effusions showed no correlation with patient age, previous treatment, residual tumor size, FIGO stage or disease outcome in survival analysis (P > 0.05). Peritoneal and pleural effusions showed simila"
74#78#gene7422135#145#diseaseC0027627 11964077-10#74#78#gene7422 11964077-10#135#145#diseaseC0027627 associated_with VEGF,metastases
0#4#gene357671#81#diseaseC0027627 11964077-11#0#4#gene3576 11964077-11#71#81#diseaseC0027627 associated_with IL-8,metastases
72#76#gene357631#43#diseaseC0280100 11964077-17#72#76#gene3576 11964077-17#31#43#diseaseC0280100 associated_with IL-8,solid tumors
72#76#gene3576303#326#diseaseC0280220 11964077-17#72#76#gene3576 11964077-17#303#326#diseaseC0280220 associated_with IL-8,stage ovarian carcinoma
72#76#gene357631#43#diseaseC0280100 11964077-17#72#76#gene3576 11964077-17#31#43#diseaseC0280100 associated_with IL-8,solid tumors
72#76#gene3576303#326#diseaseC0280220 11964077-17#72#76#gene3576 11964077-17#303#326#diseaseC0280220 associated_with IL-8,stage ovarian carcinoma
72#76#gene357631#43#diseaseC0280100 11964077-17#72#76#gene3576 11964077-17#31#43#diseaseC0280100 associated_with IL-8,solid tumors
72#76#gene3576303#326#diseaseC0280220 11964077-17#72#76#gene3576 11964077-17#303#326#diseaseC0280220 associated_with IL-8,stage ovarian carcinoma
81#85#gene742231#43#diseaseC0280100 11964077-17#81#85#gene7422 11964077-17#31#43#diseaseC0280100 associated_with VEGF,solid tumors
81#85#gene7422303#326#diseaseC0280220 11964077-17#81#85#gene7422 11964077-17#303#326#diseaseC0280220 associated_with VEGF,stage ovarian carcinoma
81#85#gene742231#43#diseaseC0280100 11964077-17#81#85#gene7422 11964077-17#31#43#diseaseC0280100 associated_with VEGF,solid tumors
81#85#gene7422303#326#diseaseC0280220 11964077-17#81#85#gene7422 11964077-17#303#326#diseaseC0280220 associated_with VEGF,stage ovarian carcinoma
81#85#gene742231#43#diseaseC0280100 11964077-17#81#85#gene7422 11964077-17#31#43#diseaseC0280100 associated_with VEGF,solid tumors
81#85#gene7422303#326#diseaseC0280220 11964077-17#81#85#gene7422 11964077-17#303#326#diseaseC0280220 associated_with VEGF,stage ovarian carcinoma
217#221#gene742231#43#diseaseC0280100 11964077-17#217#221#gene7422 11964077-17#31#43#diseaseC0280100 associated_with VEGF,solid tumors
217#221#gene7422303#326#diseaseC0280220 11964077-17#217#221#gene7422 11964077-17#303#326#diseaseC0280220 associated_with VEGF,stage ovarian carcinoma
217#221#gene742231#43#diseaseC0280100 11964077-17#217#221#gene7422 11964077-17#31#43#diseaseC0280100 associated_with VEGF,solid tumors
217#221#gene7422303#326#diseaseC0280220 11964077-17#217#221#gene7422 11964077-17#303#326#diseaseC0280220 associated_with VEGF,stage ovarian carcinoma
217#221#gene742231#43#diseaseC0280100 11964077-17#217#221#gene7422 11964077-17#31#43#diseaseC0280100 associated_with VEGF,solid tumors
217#221#gene7422303#326#diseaseC0280220 11964077-17#217#221#gene7422 11964077-17#303#326#diseaseC0280220 associated_with VEGF,stage ovarian carcinoma
233#237#gene357631#43#diseaseC0280100 11964077-17#233#237#gene3576 11964077-17#31#43#diseaseC0280100 associated_with IL-8,solid tumors
233#237#gene3576303#326#diseaseC0280220 11964077-17#233#237#gene3576 11964077-17#303#326#diseaseC0280220 associated_with IL-8,stage ovarian carcinoma
233#237#gene357631#43#diseaseC0280100 11964077-17#233#237#gene3576 11964077-17#31#43#diseaseC0280100 associated_with IL-8,solid tumors
233#237#gene3576303#326#diseaseC0280220 11964077-17#233#237#gene3576 11964077-17#303#326#diseaseC0280220 associated_with IL-8,stage ovarian carcinoma
233#237#gene357631#43#diseaseC0280100 11964077-17#233#237#gene3576 11964077-17#31#43#diseaseC0280100 associated_with IL-8,solid tumors
233#237#gene3576303#326#diseaseC0280220 11964077-17#233#237#gene3576 11964077-17#303#326#diseaseC0280220 associated_with IL-8,stage ovarian carcinoma
189#202#gene357685#113#diseaseC1514428 11964077-4#189#202#gene3576 11964077-4#85#113#diseaseC1514428 associated_with interleukin-8,primary peritoneal carcinoma
215#249#gene742285#113#diseaseC1514428 11964077-4#215#249#gene7422 11964077-4#85#113#diseaseC1514428 associated_with vascular endothelial growth factor,primary peritoneal carcinoma
251#255#gene742285#113#diseaseC1514428 11964077-4#251#255#gene7422 11964077-4#85#113#diseaseC1514428 associated_with VEGF,primary peritoneal carcinoma

DisGeNet-2017-sample

Id Subject Object Predicate Lexical cue
T2706 1494-1498 gene:7422 denotes VEGF
T2707 1555-1565 disease:C0027627 denotes metastases
T2708 1579-1583 gene:3576 denotes IL-8
T2709 1650-1660 disease:C0027627 denotes metastases
R1 T2706 T2707 associated_with VEGF,metastases
R2 T2708 T2709 associated_with IL-8,metastases

UBERON-AE

Id Subject Object Predicate Lexical cue
PD-UBERON-AE-B_T1 2074-2091 http://purl.obolibrary.org/obo/UBERON_0000175 denotes pleural effusions

performance-test

Id Subject Object Predicate Lexical cue
PD-UBERON-AE-B_T1 2074-2091 http://purl.obolibrary.org/obo/UBERON_0000175 denotes pleural effusions

DisGeNET

Id Subject Object Predicate Lexical cue
T0 743-756 gene:3576 denotes interleukin-8
T1 639-667 disease:C1514428 denotes primary peritoneal carcinoma
T2 758-762 gene:3576 denotes IL-8
T3 639-667 disease:C1514428 denotes primary peritoneal carcinoma
T4 769-803 gene:7422 denotes vascular endothelial growth factor
T5 639-667 disease:C1514428 denotes primary peritoneal carcinoma
T6 805-809 gene:7422 denotes VEGF
T7 639-667 disease:C1514428 denotes primary peritoneal carcinoma
R1 T0 T1 associated_with interleukin-8,primary peritoneal carcinoma
R2 T2 T3 associated_with IL-8,primary peritoneal carcinoma
R3 T4 T5 associated_with vascular endothelial growth factor,primary peritoneal carcinoma
R4 T6 T7 associated_with VEGF,primary peritoneal carcinoma